Disease Markers / 2020 / Article / Tab 1 / Research Article
The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis Table 1 Characteristics of included studies.
Author Year Country Specimen Control group miRNA as biomarker Case size Control size miRNA as control Relative expression SEN SPE TP FP FN TN Wang et al. [7 ] 2019 China Serum HP miR-200c 110 116 miR-103 High 0.809 0.517 89 56 21 60 Wang et al. [7 ] 2019 China Serum HP miR-205 110 116 miR-103 High 0.764 0.526 84 55 26 61 Kim et al. [8 ] 2019 Korea Serum exosome PBOD miR-200c 48 20 RNU48 High 0.729 0.9 35 2 13 18 Kim et al. [8 ] 2019 Korea Serum exosome PBOD miR-145 48 20 RNU48 High 0.917 0.868 44 3 4 17 Márton et al. [9 ] 2019 Hungary Plasma HP miR-200a 28 60 miR-103 High 0.857 0.783 24 13 4 47 Márton et al. [9 ] 2019 Hungary Plasma HP miR-200b 28 60 miR-103 High 0.679 0.9 19 6 9 54 Márton et al. [9 ] 2019 Hungary Plasma HP miR-200c 28 60 miR-103 High 0.714 0.867 20 8 8 52 Márton et al. [9 ] 2019 Hungary Plasma HP miR-141 28 60 miR-103 High 0.857 0.9 24 6 4 54 Márton et al. [9 ] 2019 Hungary Plasma HP miR-429 28 60 miR-103 High 0.857 0.683 24 19 4 41 Zuberi et al. [10 ] 2019 India Serum HP miR-145 70 70 RNU6B Low 0.991 0.957 69 3 1 67 Meng et al. [11 ] 2016 Germany Serum HP miR-200a 60 32 miR-484 High 0.672 0.9 40 3 20 29 Meng et al. [11 ] 2016 Germany Serum HP miR-200b 60 32 miR-484 High 0.931 0.9 56 3 4 29 Meng et al. [11 ] 2016 Germany Serum HP miR-200c 60 32 miR-484 High 0.845 0.85 51 5 9 27 Zhu et al. [12 ] 2017 China Serum PBOD miR-125b 135 54 miR-16 High 0.756 0.685 102 17 33 37 Zuberi et al. [13 ] 2016 India Serum HP miR-125b 70 70 RNU6 High 0.623 0.771 44 16 26 54 Meng et al. [14 ] 2015 Germany Serum HP miR-429 180 66 miR-484 High 0.594 0.955 107 3 73 63 Gao and Wu [15 ] 2015 China Serum HP miR-141 93 50 High 0.69 0.72 64 14 29 36 Gao and Wu [15 ] 2015 China Serum HP miR-200c 93 50 High 0.72 0.7 67 15 26 35 Zheng et al. [16 ] 2013 China Plasma HP miR-205 134 70 High 0.301 0.942 40 4 94 66 Kan et al. [17 ] 2012 Australia Serum HP miR-200a 28 28 miR-103 High 0.857 0.357 24 18 4 10 Kan et al. [17 ] 2012 Australia Serum HP miR-200b 28 28 miR-103 High 0.857 0.357 24 18 4 10 Kan et al. [17 ] 2012 Australia Serum HP miR-200c 28 28 miR-103 High 0.714 0.571 20 12 8 16
Abbreviation: HP—healthy people; PBOD—patients with benign ovarian disease; SEN—sensitivity; SPE—specificity; TP—true positive; FP—false positive; FN—false negative; TN—true negative.
Relative expression for microRNA as a biomarker of the case group compared to the control group.